Similar Outcome of Calreticulin Type I and Calreticulin Type II Mutations Following RIC Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.128
Full Text
Open PDFAbstract
Available in full text
Date
May 23, 2016
Authors
Publisher
Springer Science and Business Media LLC